In light of the recent news on the Oxford Covid-19 vaccine, John Rountree, was invited on CNBC to discuss the outlook.
Discover John’s previous comments on the vaccine here.
I agree to Novasecta’s privacy policy (required)
Media
Oxford vaccine news is very encouraging (CNBC)
In light of the recent news on the Oxford Covid-19 vaccine, John Rountree, was invited on CNBC to discuss the outlook.
Discover John’s previous comments on the vaccine here.
Related
Media
How Pharma Manages Organisational Complexity (MedNous)
DiscoverHow R&D Teams Create Value from On-Market Products (MedNous)
DiscoverHow European MidPharmas have Grown Profits (MedNous)
Discover